GC Wealth Management RIA’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
GC Wealth Management RIA's NVS Position: Q2 2026 in Review
GC Wealth Management RIA increased its Novartis (NVS) stake by 26% in Q2 2026, buying an estimated $199K and bringing the position to 6,349 shares worth $995K. The position accounts for 0.06% of the portfolio, ranked #227.
GC Wealth Management RIA first reported a position in NVS in Q4 2023 and has held it in 8 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- GC Wealth Management RIA held 6,349 shares of Novartis worth $995K as of Q2 2026.
- GC Wealth Management RIA bought 1,327 Novartis shares in Q2 2026, an estimated $199K.
- Novartis made up 0.06% of GC Wealth Management RIA's portfolio in Q2 2026, its #227 holding.
- GC Wealth Management RIA first reported a position in Novartis in Q4 2023 and has held it in 8 quarters since.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.